GLP-1s Explained: The Facts, Fiction, and What's Next with Joe Zucchi, PA-C, MPAS (ep – 92)

GLP-1 medications are everywhere right now, but the confusion around them runs just as deep as the excitement. In this episode, Dr. Ginger Hultin sits down with Joe Zucchi, PA and clinical supervisor at Transition Medical Weight Loss, for a deep dive into everything you've been wondering about these medications.

Joe walks through the surprising history of GLP-1s, breaks down exactly how they work in the body, and tackles the stigma that still surrounds obesity medicine. The conversation covers real clinical data on side effects, including the truth behind the cancer warnings, what the research shows about muscle and bone loss, and practical strategies for managing GI symptoms. Joe also shares what's coming next in the pipeline, from triple-agonist medications to once-monthly injections.

Whether you're considering a GLP-1, currently taking one, or just want the facts, this episode is designed to be a shame-free, evidence-based resource you can trust.

In this episode, we’ll cover:

[00:02:35] The long history behind GLP-1 medications

[00:06:03] GLP-1, GIP, and the evolution to dual and triple agonists

[00:08:18] Pushing back on the stigma in obesity medicine

[00:09:56] What happens when someone comes off the medication

[00:13:04] Inside the clinical trial process and what FDA approval requires

[00:19:30] Pancreatitis and thyroid cancer concerns, explained

[00:21:30] What the research shows about muscle and bone loss

[00:25:11] GI side effects and practical ways to manage them